Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis

Add time:08/15/2019    Source:sciencedirect.com

The neuroleptic drug thioridazine has been recently repositioned as possible anti-tubercular drug. Thioridazine showed anti-tubercular activity against drug resistant mycobacteria but it is endowed with adverse side effects. A small library of thioridazine derivatives has been designed through the replacement of the piperidine and phenothiazine moieties, with the aim to improve the anti-tubercular activity and to reduce the cytotoxic effects. Among the resulting compounds, the indole derivative 12e showed an antimycobacterial activity significantly better than thioridazine and a cytotoxicity 15-fold lower.

We also recommend Trading Suppliers and Manufacturers of THIORIDAZINE HYDROCHLORIDE (cas 1257-76-7). Pls Click Website Link as below: cas 1257-76-7 suppliers

Prev:Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis
Next:Thermodynamic modelling for solubility of 5-chloro-1-methyl-4-nitroimidazole in eleven organic solvents from T = (283.15 to 318.15) K)